{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreie5q3csfib276toslnru2slv4yvw6aiepfcccw4axuw7pw4slvzei",
    "uri": "at://did:plc:itdwwrxvp5plq2i6rsanlqio/app.bsky.feed.post/3mpq7ymn3x7u2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibaofqrfd2bailalx3yuberwka4lpk4jx6pcamzgjg4pd4x6p62vm"
    },
    "mimeType": "image/jpeg",
    "size": 100058
  },
  "path": "/health/493926/medicare-bridge-cover-weight-loss-glp-1-zepbound-wegovy-foundayo",
  "publishedAt": "2026-07-02T20:00:00.000Z",
  "site": "https://www.vox.com",
  "tags": [
    "Good Medicine",
    "Health",
    "Health Care",
    "Policy",
    "Public Health"
  ],
  "textContent": "The latest breakthrough for GLP-1 drugs isn’t scientific. It’s financial. As of July 1, Medicare is providing coverage of GLP-1 medications for weight loss for just a $50 co-pay, potentially enabling millions more Americans to get onto this much-hyped new class of drugs. Medicare’s GLP-1 Bridge Program, as it is called, is technically a one-year […]",
  "title": "Medicare is now offering $50 GLP-1 prescriptions. The US may never be the same.",
  "updatedAt": "2026-07-02T14:41:35.000Z"
}